Innoviva, Inc. Common Stock (INVA) is a publicly traded Healthcare sector company. As of August 5, 2026, INVA trades at $20.56 with a market cap of $1.54B and a P/E ratio of 2.86. INVA moved -1.75% today. Year to date, INVA is +2.60%; over the trailing twelve months it is +11.23%. Its 52-week range spans $16.52 to $25.15. Analyst consensus is buy with an average price target of $35.33. Rallies surfaces INVA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
INVA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. INVA recently traded at $20.56. Market cap is $1.54B. P/E ratio is 2.86. Revenue is $420.69M.
| Metric | Value |
|---|---|
| Price | $20.56 |
| Market Cap | $1.54B |
| P/E Ratio | 2.86 |
| EPS | $7.20 |
| Dividend Yield | 0.25% |
| 52-Week High | $25.15 |
| 52-Week Low | $16.52 |
| Volume | 543.10K |
| Avg Volume | 0 |
| Revenue (TTM) | $420.69M |
| Net Income | $504.34M |
| Gross Margin | 73.73% |
3 analysts cover INVA: 0 strong buy, 2 buy, 0 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $35.33.